An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Turner's Syndrome
Interventions
DRUG

ZOMACTON

Trial Locations (6)

33000

Centre d'Endocrinologie Pediatrique, 25 rue Boudet, Bordeaux

76083

Service de Pédiatrie, Groupe Hospitalier du Havre, 55 bis, rue Gustave Flaubert, Le Havre

775 20

Faculty Hospital Olomouc, Children's Clinic, Endocrinology Outpatient Department, I.P.Pavlova str. 6,, Olomouc

100 81

Faculty Hospital Kralovske Vinohrady, Children's Clinic, Vinohradska str. 159, Prague

401 13

Masaryk Hospital Usti nad Labem, Children's Clinic, Building D2, Endocrinology Outpatient Department, Socialni pece 12a, Ústí nad Labem

10007 MB

Vu medisch centrum, Paediatrics, De Boelelaan 1117, PO Box 7057, Amsterdam

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY